Literature DB >> 10431380

Oncospheres of Taenia solium and T. saginata asiatica develop into metacestodes in normal and immunosuppressed mice.

I C Wang1, Y X Ma, J X Guo, W C Chung, S C Lu, A Ito, P C Fan.   

Abstract

Normal and immunosuppressed mice were infected with oncospheres of Taenia saginata asiatica and T. solium. Although normal ICR mice were not susceptible to these two parasites, cysticerci were recovered from the immunosuppressed ones following venous injection. For T. s. asiatica, immunosuppressed ICR mice had an infection rate of 12.5% and six cysticerci of this parasite were recovered from three males. After injection of T. solium oncospheres, a high infection rate of 57% was obtained and 23 cysticerci were collected from 13 male immunosuppressed ICR mice. The immunosuppressed C57 mice had the highest infection rate (100%) and cysticercus recovery rate (2.4%) for T. solium. The infection rate and cysticercus recovery rate in six normal C57 mice were 40% and 3% respectively. The immunosuppressed ICR, Balb/c and C3H mice were also susceptible to T. s. asiatica.

Entities:  

Mesh:

Year:  1999        PMID: 10431380     DOI: 10.1017/s0022149x99000281

Source DB:  PubMed          Journal:  J Helminthol        ISSN: 0022-149X            Impact factor:   2.170


  3 in total

1.  Rodent model for long-term maintenance and development of the viable cysticerci of Taenia saginata asiatica.

Authors:  I C Wang; W C Chung; S C Lu; P C Fan
Journal:  Korean J Parasitol       Date:  2000-12       Impact factor: 1.341

2.  Experimental animal models and their use in understanding cysticercosis: A systematic review.

Authors:  Muloongo C Sitali; Veronika Schmidt; Racheal Mwenda; Chummy S Sikasunge; Kabemba E Mwape; Martin C Simuunza; Clarissa P da Costa; Andrea S Winkler; Isaac K Phiri
Journal:  PLoS One       Date:  2022-07-19       Impact factor: 3.752

Review 3.  Taenia solium Cysticercosis and Its Impact in Neurological Disease.

Authors:  Hector H Garcia; Armando E Gonzalez; Robert H Gilman
Journal:  Clin Microbiol Rev       Date:  2020-05-27       Impact factor: 26.132

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.